FDA clears new Physio-Control defibrillator/monitor
Physio-Control, a wholly owned subsidiary of Medtronic, has received clearance by the FDA to market the LIFEPAK 20e defibrillator/monitor within the U.S.
The 20e is an enhancement of the LIFEPAK 20 defibrillator/monitor, offering the capabilities of the LIFEPAK 20 device, along with a more powerful lithium-ion battery, according to the Redmond, Wash.-based Physio. Additionally, a new on-screen fuel gauge displays the real-time status of available battery capacity so clinicians can monitor remaining use time.
The company said its 20e also was developed to be easily transported, helping hospitals meet the Joint Commission standard.
The 20e is an enhancement of the LIFEPAK 20 defibrillator/monitor, offering the capabilities of the LIFEPAK 20 device, along with a more powerful lithium-ion battery, according to the Redmond, Wash.-based Physio. Additionally, a new on-screen fuel gauge displays the real-time status of available battery capacity so clinicians can monitor remaining use time.
The company said its 20e also was developed to be easily transported, helping hospitals meet the Joint Commission standard.